Market by Type, Form, Livestock, Application, End-user, and Country | Forecast 2021-2028
As
per Triton’s research report, the Asia-Pacific eubiotics market is estimated to
display growth at a compound annual growth rate of 7.98% during the forecasted
period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered in this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of Asia-Pacific
In
the Asia-Pacific, the rising disposable income has offered a wider dining
opportunity to consumers. As per the Organization for Economic Cooperation and
Development and the Food and Agriculture Organization, beef consumption in Asia
is likely to surge over the next few years. Other than this, the growing meat
consumption is anticipated to increase the demand for eubiotics across the
major cities. Furthermore, the changing lifestyle and ban on antibiotics in
some nations are driving the growth of the eubiotics market in the APAC region.
China,
for instance, is among the largest meat importers, with pork products
dominating the majority of the segment. Additionally, it plays a key role in
the growth of agricultural products demand. Furthermore, the government has
made efforts to control antibiotic use in animals. For instance, the country
has released a prohibited list of antibiotics, along with classified management
of prescription drugs. Therefore, these factors, coupled with the ban on
antibiotic use, are estimated to augment the development of the eubiotics
market across China in the next few years.
Behn
Meyer Group is engaged in offering fertilizer, animal nutrition, food, home
& personal care, water treatment, rubber, and other products. In addition,
it has evolved as a specialty supplier for various industries globally. Its
product portfolio includes Azomite that provides trace elements required for
protein fertility and synthesis. The company has operations across various
countries in the APAC region, including Singapore, Malaysia, and Vietnam.
1. ASIA-PACIFIC
EUBIOTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON EUBIOTICS MARKET
2.2. KEY
INSIGHTS
2.2.1. EUBIOTICS
AS AN ALTERNATIVE TO ANTIBIOTICS
2.2.2. APPLICATIONS
OF EUBIOTICS IN CALVES' GUT HEALTH
2.2.3. DEVELOPING
FOOD ADDITIVE PLATFORM BASED ON GRAINS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. PRODUCT
LAUNCHES
2.6.4. EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISING
MEAT CONSUMPTION
2.7.2. GROWING
AWARENESS AND CONCERNS REGARDING ANIMAL HEALTH
2.7.3. INCREASING
DEMAND FOR MANUFACTURED FEEDS
2.8. MARKET
CHALLENGES
2.8.1. UNAWARENESS
ABOUT EUBIOTICS
2.9. MARKET
OPPORTUNITIES
2.9.1. GOVERNMENT
SUPPORT FOR EUBIOTICS USE
2.9.2. PROBIOTICS
SPRAY COATINGS
2.9.3. ESSENTIAL
OILS FOR NECROTIC ENTERITIS
3. ASIA-PACIFIC
EUBIOTICS MARKET OUTLOOK - BY TYPE
3.1. PROBIOTICS
3.2. ORGANIC
ACID
3.3. PREBIOTICS
3.4. ESSENTIAL
OILS
4. ASIA-PACIFIC
EUBIOTICS MARKET OUTLOOK - BY FORM
4.1. DRY
4.2. LIQUID
5. ASIA-PACIFIC
EUBIOTICS MARKET OUTLOOK - BY LIVESTOCK
5.1. SWINE
5.2. POULTRY
5.3. RUMINANTS
5.4. AQUACULTURE
5.5. OTHER
LIVESTOCK
6. ASIA-PACIFIC
EUBIOTICS MARKET OUTLOOK - BY APPLICATION
6.1. GUT
HEALTH
6.2. IMMUNITY
6.3. YIELD
MANAGEMENT
6.4. OTHER
APPLICATIONS
7. ASIA-PACIFIC
EUBIOTICS MARKET OUTLOOK - BY END-USER
7.1. ANIMALS
7.2. HUMANS
8. ASIA-PACIFIC
EUBIOTICS MARKET – REGIONAL OUTLOOK
8.1. CHINA
8.2. JAPAN
8.3. INDIA
8.4. SOUTH
KOREA
8.5. ASEAN
COUNTRIES
8.6. AUSTRALIA
& NEW ZEALAND
8.7. REST
OF ASIA-PACIFIC
9. COMPETITIVE
LANDSCAPE
9.1. ANPARIO
PLC
9.2. ARCHER
DANIELS MIDLAND
9.3. BASF
SE
9.4. BEHN
MEYER GROUP
9.5. BENEO
GMBH
9.6. CARGILL
INC
9.7. CHR
HANSEN HOLDING AS
9.8. DUPONT
DE NEMOURS INC
9.9. KEMIN
INDUSTRIES INC
9.10. KONINKLIJKE
DSM NV
9.11. LALLEMAND
INC
9.12. LESAFFRE
9.13. NEOSPARK
DRUGS AND CHEMICALS PRIVATE LIMITED
9.14. NOVUS
INTERNATIONAL INC
9.15. YARA
INTERNATIONAL ASA
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: COUNTRIES WITH
THE HIGHEST ANNUAL MEAT CONSUMPTION
TABLE 4: MAJOR LIVESTOCK
DISEASES IN THE WORLD
TABLE 5: ASIA-PACIFIC
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: ASIA-PACIFIC EUBIOTICS MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: ASIA-PACIFIC EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 4: ASIA-PACIFIC EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN $
MILLION)
FIGURE 5: ASIA-PACIFIC EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 6: ASIA-PACIFIC EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028 (IN
$ MILLION)
FIGURE 7: ASIA-PACIFIC EUBIOTICS MARKET, BY FORM, 2020 & 2028 (IN %)
FIGURE 8: ASIA-PACIFIC EUBIOTICS MARKET, BY DRY, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $
MILLION)
FIGURE 10: ASIA-PACIFIC EUBIOTICS MARKET, BY LIVESTOCK, 2020 & 2028
(IN %)
FIGURE 11: ASIA-PACIFIC EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $
MILLION)
FIGURE 12: ASIA-PACIFIC EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $
MILLION)
FIGURE 13: ASIA-PACIFIC EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $
MILLION)
FIGURE 14: ASIA-PACIFIC EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN $
MILLION)
FIGURE 15: ASIA-PACIFIC EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028
(IN $ MILLION)
FIGURE 16: ASIA-PACIFIC EUBIOTICS MARKET, BY APPLICATION, 2020 & 2028
(IN %)
FIGURE 17: ASIA-PACIFIC EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $
MILLION)
FIGURE 18: ASIA-PACIFIC EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $
MILLION)
FIGURE 19: ASIA-PACIFIC EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028
(IN $ MILLION)
FIGURE 20: ASIA-PACIFIC EUBIOTICS MARKET, BY OTHER APPLICATIONS,
2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC EUBIOTICS MARKET, BY END-USER, 2020 & 2028
(IN %)
FIGURE 22: ASIA-PACIFIC EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $
MILLION)
FIGURE 23: ASIA-PACIFIC EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $
MILLION)
FIGURE 24: ASIA-PACIFIC EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 &
2028 (IN %)
FIGURE 25: CHINA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: JAPAN EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: INDIA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: SOUTH KOREA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: ASEAN COUNTRIES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: AUSTRALIA & NEW ZEALAND EUBIOTICS MARKET 2021-2028 (IN $
MILLION)
FIGURE 31: REST OF ASIA-PACIFIC EUBIOTICS MARKET 2021-2028 (IN $ MILLION)